Publication | Closed Access

Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial

ObesityMetabolic SyndromeInsulin ResistanceHepatologyLipid MetabolismMedicineLiver PhysiologyDiabetesLiver DiseaseFatty Liver DiseaseMetabolismPharmacologyHealth Sciences